Why Shares of Stoke Therapeutics Plummeted in September
After top performance in August, the biotech was hit hard.
Stoke Therapeutics Inc(STOK)
Nasdaq Global Select
STOK
$34.35
-$0.89
-2.5%
Price as of April 9, 2021, 8:00 p.m. EDT
View Interactive STOK Charts
Interactive Chart
News & Analysis: Stoke Therapeutics Inc
Are There Good Investments Among 2019's Biotech IPOs?
Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?
